As is supported by the common practice of prescribing low-dose quetiapine and clozapine for PDP at doses too low to antagonize the D2 receptor, but sufficiently high doses to inversely agonize the 5-HT2A receptors.[11] Eight case reports have been reported in five papers on the use of mirtazapine in the treatment of hives as of 2017.[125]